Alibaba Health (Germany) Performance
| TWY Stock | EUR 0.41 0.01 2.38% |
The firm shows a Beta (market volatility) of -0.79, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Alibaba Health are expected to decrease at a much lower rate. During the bear market, Alibaba Health is likely to outperform the market. At this point, Alibaba Health Infor has a negative expected return of -0.14%. Please make sure to confirm Alibaba Health's skewness, day median price, and the relationship between the treynor ratio and daily balance of power , to decide if Alibaba Health Infor performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Alibaba Health Information has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 7.3 B | |
| Total Cashflows From Investing Activities | 1.9 B |
Alibaba |
Alibaba Health Relative Risk vs. Return Landscape
If you would invest 46.00 in Alibaba Health Information on October 20, 2024 and sell it today you would lose (5.00) from holding Alibaba Health Information or give up 10.87% of portfolio value over 90 days. Alibaba Health Information is currently producing negative expected returns and takes up 3.2059% volatility of returns over 90 trading days. Put another way, 28% of traded stocks are less volatile than Alibaba, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Alibaba Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alibaba Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alibaba Health Information, and traders can use it to determine the average amount a Alibaba Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.044
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TWY |
Estimated Market Risk
| 3.21 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alibaba Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alibaba Health by adding Alibaba Health to a well-diversified portfolio.
Alibaba Health Fundamentals Growth
Alibaba Stock prices reflect investors' perceptions of the future prospects and financial health of Alibaba Health, and Alibaba Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alibaba Stock performance.
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 14.05 B | |||
| Shares Outstanding | 13.52 B | |||
| Price To Book | 7.98 X | |||
| Price To Sales | 0.56 X | |||
| Revenue | 20.58 B | |||
| EBITDA | (248.7 M) | |||
| Book Value Per Share | 1.11 X | |||
| Cash Flow From Operations | 424.36 M | |||
| Total Asset | 19.2 B | |||
About Alibaba Health Performance
By analyzing Alibaba Health's fundamental ratios, stakeholders can gain valuable insights into Alibaba Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Alibaba Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Alibaba Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Alibaba Health Infor performance evaluation
Checking the ongoing alerts about Alibaba Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alibaba Health Infor help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alibaba Health Infor generated a negative expected return over the last 90 days | |
| Alibaba Health Infor has some characteristics of a very speculative penny stock | |
| Alibaba Health Infor has high historical volatility and very poor performance | |
| Alibaba Health Infor has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 20.58 B. Net Loss for the year was (265.56 M) with profit before overhead, payroll, taxes, and interest of 4.11 B. | |
| About 65.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Alibaba Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alibaba Health's stock is overvalued or undervalued compared to its peers.
- Examining Alibaba Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alibaba Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alibaba Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alibaba Health's stock. These opinions can provide insight into Alibaba Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Alibaba Stock analysis
When running Alibaba Health's price analysis, check to measure Alibaba Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alibaba Health is operating at the current time. Most of Alibaba Health's value examination focuses on studying past and present price action to predict the probability of Alibaba Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alibaba Health's price. Additionally, you may evaluate how the addition of Alibaba Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |